de Jong B - Search Results

1

Worldwide clinical experience with the first marketed leukotriene receptor antagonist.

Barnes NC, de Jong B, Miyamoto T. Barnes NC, et al. Among authors: de jong b. Chest. 1997 Feb;111(2 Suppl):52S-60S. doi: 10.1378/chest.111.2_supplement.52s. Chest. 1997. PMID: 9042027 Review.

2

A pragmatic approach to dealing with fingolimod-related lymphopaenia in Europe.

Giovannoni G, de Jong B, Derfuss T, Izquierdo G, Mazibrada G, Molyneux P, Nicholas R, Overell J, Ziemssen T, Juliusson G. Giovannoni G, et al. Among authors: de jong b. Mult Scler Relat Disord. 2015 Jan;4(1):83-4. doi: 10.1016/j.msard.2014.09.215. Epub 2014 Oct 13. Mult Scler Relat Disord. 2015. PMID: 25787058 No abstract available.

3

Improved patient-reported health impact of multiple sclerosis: The ENABLE study of PR-fampridine.

Macdonell R, Nagels G, Laplaud DA, Pozzilli C, de Jong B, Martins da Silva A, Nicholas R, Lechner-Scott J, Gaebler JA, Agarwal S, Wang P, Yeh M, Hovenden M, Soelberg Sørensen P. Macdonell R, et al. Among authors: de jong b. Mult Scler. 2016 Jun;22(7):944-54. doi: 10.1177/1352458515606809. Epub 2015 Oct 7. Mult Scler. 2016. PMID: 26447066 Clinical Trial.

4

Severe cutaneous adverse event in a daclizumab-treated multiple sclerosis patient.

van Rossum JA, Peters MAD, van der Valk P, de Jong BA. van Rossum JA, et al. Mult Scler Relat Disord. 2019 Sep;34:38-40. doi: 10.1016/j.msard.2019.06.006. Epub 2019 Jun 8. Mult Scler Relat Disord. 2019. PMID: 31228714 No abstract available.

5

Neuromyelitis optica spectrum disorder mimicking multiple sclerosis.

van Rooij LC, Wattjes MP, de Jong BA, van Oosten BW. van Rooij LC, et al. Mult Scler Relat Disord. 2017 Oct;17:54-56. doi: 10.1016/j.msard.2017.06.009. Epub 2017 Jun 29. Mult Scler Relat Disord. 2017. PMID: 29055475

6

Piet Mondrian's trees and the evolution in understanding multiple sclerosis, Charcot Prize Lecture 2011.

Steinman L, Axtell RC, Barbieri D, Bhat R, Brownell SE, de Jong BA, Dunn SE, Grant JL, Han MH, Ho PP, Kuipers HF, Kurnellas MP, Ousman SS, Rothbard JB. Steinman L, et al. Among authors: de jong ba. Mult Scler. 2013 Jan;19(1):5-14. doi: 10.1177/1352458512470730. Mult Scler. 2013. PMID: 23303879

7

Protective effect of an elastase inhibitor in a neuromyelitis optica-like disease driven by a peptide of myelin oligodendroglial glycoprotein.

Herges K, de Jong BA, Kolkowitz I, Dunn C, Mandelbaum G, Ko RM, Maini A, Han MH, Killestein J, Polman C, Goodyear AL, Dunn J, Steinman L, Axtell RC. Herges K, et al. Mult Scler. 2012 Apr;18(4):398-408. doi: 10.1177/1352458512440060. Epub 2012 Feb 16. Mult Scler. 2012. PMID: 22343184 Free PMC article.

8

Anxiety is more important than depression in MS - Commentary.

de Jong BA, Uitdehaag BM. de Jong BA, et al. Mult Scler. 2018 Apr;24(4):444-445. doi: 10.1177/1352458518756516. Epub 2018 Jan 30. Mult Scler. 2018. PMID: 29381123 Free PMC article. No abstract available.

9

T helper type 1 and 17 cells determine efficacy of interferon-beta in multiple sclerosis and experimental encephalomyelitis.

Axtell RC, de Jong BA, Boniface K, van der Voort LF, Bhat R, De Sarno P, Naves R, Han M, Zhong F, Castellanos JG, Mair R, Christakos A, Kolkowitz I, Katz L, Killestein J, Polman CH, de Waal Malefyt R, Steinman L, Raman C. Axtell RC, et al. Nat Med. 2010 Apr;16(4):406-12. doi: 10.1038/nm.2110. Epub 2010 Mar 28. Nat Med. 2010. PMID: 20348925 Free PMC article.

10

The Effectiveness of Mindfulness-Based Stress Reduction on Psychological Distress and Cognitive Functioning in Patients with Multiple Sclerosis: a Pilot Study.

Blankespoor RJ, Schellekens MPJ, Vos SH, Speckens AEM, de Jong BA. Blankespoor RJ, et al. Mindfulness (N Y). 2017;8(5):1251-1258. doi: 10.1007/s12671-017-0701-6. Epub 2017 Mar 28. Mindfulness (N Y). 2017. PMID: 28989549 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results